Burke; Paul A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Burke; Paul A..The latest application filed is for "breach thread protector".

Company Profile

2.14.16

Burke; Paul A. - Rogersville TN US
Burke; Paul A. - Eldersburg MD US
Burke; Paul A. - Boston MA
Burke; Paul A. - Philadelphia PA
Burke; Paul A. - Oxnard CA
Burke, Paul A. - Medford MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Breach Thread Protector App 20190086182 - Burke; Paul A.	2019-03-21
Breach thread protector Grant 9,970,734 - Burke May 15, 2	2018-05-15
Breach Thread Protector App 20180058803 - Burke; Paul A.	2018-03-01
Breech thread protector Grant 9,759,514 - Burke September 12, 2	2017-09-12
Breech Thread Protector App 20150276342 - Burke; Paul A.	2015-10-01
Preparation of Lipid Nanoparticles App 20130037977 - Burke; Paul A. ; et al.	2013-02-14
Microencapsulation and sustained release of biologically active polypeptides Grant 8,129,339 - Costantino , et al. March 6, 2	2012-03-06
Microencapsulation and sustained release of biologically active polypeptides App 20090281034 - Costantino; Henry R. ; et al.	2009-11-12
Method of modifying the release profile of sustained release compositions App 20080057131 - Dasch; James R. ; et al.	2008-03-06
Composition for sustained release of non-aggregated erythropoietin App 20040224016 - Zale, Stephen E. ; et al.	2004-11-11
Method of modifying the release profile of sustained release compositions App 20040121009 - Dasch, James R. ; et al.	2004-06-24
Device for the sustained release of aggregation-stabilized, biologically active agent App 20030133979 - Burke, Paul A. ; et al.	2003-07-17
Microencapsulation and sustained release of oligonucleotides Grant 6,555,525 - Burke April 29, 2	2003-04-29
Composition for sustained release of non-aggregated erythropoietin App 20030035845 - Zale, Stephen E. ; et al.	2003-02-20
Method for fabricating polymer-based controlled-release devices App 20030031701 - Burke, Paul A.	2003-02-13
Device for the sustained release of aggregation-stabilized, biologically active agent Grant 6,514,533 - Burke , et al. February 4, 2	2003-02-04
Methods for fabricating polymer-based controlled release devices Grant 6,455,074 - Tracy , et al. September 24, 2	2002-09-24
Microencapsulation and sustained release of oligonucleotides App 20020064557 - Burke, Paul A.	2002-05-30
Microencapsulation and sustained release of oligonucleotides Grant 6,265,389 - Burke July 24, 2	2001-07-24
Method for fabricating polymer-based controlled-release devices Grant 6,183,781 - Burke February 6, 2	2001-02-06
Methods for fabricating polymer-based controlled release devices Grant 5,989,463 - Tracy , et al. November 23, 1	1999-11-23
Method for fabricating polymer-based controlled-release devices Grant 5,817,343 - Burke October 6, 1	1998-10-06
Composition for sustained release of non-aggregated erythropoietin Grant 5,716,644 - Zale , et al. February 10, 1	1998-02-10
Composition for sustained release of non-aggregated erythropoietin Grant 5,674,534 - Zale , et al. October 7, 1	1997-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.